The Mount Sinai Alzheimer's Disease Research Center (ADRC), a nationally renowned center of excellence since 1984, is a comprehensive clinical program and research facility dedicated to the study and treatment of both normal aging and Alzheimer's disease.
Our ADRC, with its team of experts in geriatrics, geriatric psychiatry and psychology, neurology, pathology, and radiology, diagnoses and provides patient care for those with memory disorders. Our clinicians and neuroscientists also conduct research into the causes and treatment of dementia, and sponsors educational programs for health care professionals and community groups. Caregiver programs and support groups are also available. All services are available in both English and Spanish.
Mount Sinai's clinical research programs are available to those with Alzheimer's disease as well as healthy seniors. Both our clinical and lab research are supported by the National Institute on Aging and aim to improve diagnosis, delay disease progression, and enhance well-being of those affected by Alzheimer's disease, as well as to study the normal aging process.
A New Clinical Trial of a Red Wine Derivative By Judith Neugroschl, M.D. The Mount Sinai ADRC is excited to announce our participation in a new nationwide study examining the effect of resveratrol in patients with mild to moderate Alzheimer’s disease (AD). What makes this trial unique is that in addition to the traditional paper [...]
Over the past 25 years there have been few changes in the diagnosis of Alzheimer disease (AD) even though our knowledge of the disease and its progression has grown. For example, the current criteria have age cutoffs (between 40 and 90 years of age), but we know now that many people living into their 90’s [...]
The first evidence of a link between history of head injury and risk for developing Alzheimer’s disease (AD) was a case report of AD pathology in the brain of a 38 year-old man who had suf- fered a single episode of a head injury 16 years earlier. This finding lead to the idea that head [...]
A center of excellence dedicated to the study of Alzheimer’s disease and normal aging that is supported by the National Institute on Aging, a branch of the National Institutes of Health.